MEF2C and cancer: Interestingly, Myocyte Enhancer Factor 2C (MEF2C) has been documented in pathways of organelle biogenesis and maintenance and transcriptional misregulation in cancer, which involved DNA-binding transcription factor activity and protein heterodimerization activity.